Therefore, we aimed to investigate the associations between pre‐diagnostic circulating FABP‐4 and CRC‐specific mortality, non‐CRC‐specific mortality, and all‐cause mortality in participants with incident CRC in the EPIC cohort. Here, FABP4 is linked to colorectal carcinoma.